Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study
Harrys A. Torres(The University of Texas MD Anderson Cancer Center), Bruno Granwehr(The University of Texas MD Anderson Cancer Center), Ying Jiang(The University of Texas MD Anderson Cancer Center), Jeff Hosry(The University of Texas MD Anderson Cancer Center), Andreas Kyvernitakis(The University of Texas MD Anderson Cancer Center), Parag Mahale(National Cancer Institute), Issam Raad, Ethan Miller(The University of Texas MD Anderson Cancer Center), Ahmed O. Kaseb(The University of Texas MD Anderson Cancer Center), Felipe Samaniego(The University of Texas MD Anderson Cancer Center), Minas P. Economides(NYU Langone Health), Georgios Angelidakis(The University of Texas MD Anderson Cancer Center), Boris Blechacz(South Texas Veterans Health Care System), Aung Naing(The University of Texas MD Anderson Cancer Center)
Cited by 20
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Guidelines for the Management of Intravascular Catheter-Related Infections
|Clinical Infectious Diseases|2001|1.5k
Cholangiocarcinoma
|Hepatology|2008|689